This website uses cookies to enhance the user experience.
21st logo
||
O

ONCOGENE AS825 818 642

Counseling
Limited company
Gunnar Randers' vei 12 2007 KJELLER, Norge

ONCOGENE AS

Operating
Tilby genetiske analyser for privatpersoner, forskning og annen næringsvirksomhet, samt bioinformatikk analyse av alle slag for presisjonsmedisin og personalisert terapi, og annet som naturlig faller sammen med dette.

Keywords

physicalchemicalanalytical testingmaterialsproductsacoustic testingvibration testingcompositionpurityfood hygieneveterinary controlperformance testingtype approvalcertificationclassification

Links

Organization

Chairman of the board
Years since formation
6 years
since Oct 21, 2020
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
300
1 share class
Total number of shareholders
7
3 companies, 4 persons
Belongs to group of

Financials

Total operating income 2025
1,194,217
NOK
Annual total result 2025
-2,309,383
NOK
Total equity 2025
32,197
NOK
Last update: Aug 3, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO
67 %
indirectly

Board

NameRoleShares
Chairman
67 %
indirectly
Board Member
5 %
directly
Board Member
5 %
directly
ResignedBoard Member-

Others

NameRoleShares
R
REGNSKAP.DIGITAL AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Chairman, Managing Director/CEO
67 %
indirectly
-
10 %
indirectly
Board Member
5 %
directly
Board Member
5 %
directly
-
5 %
directly
-
3 %
directly
-
2.5 %
indirectly
-
2.5 %
indirectly
Last update: Feb 24, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
M
MODUS I AS
Ordinary shares
201
67 %
E
ECONTO AS
Ordinary shares
30
10 %
Ordinary shares
15
5 %
M
MAKRI INVEST AS
Ordinary shares
15
5 %
Ordinary shares
15
5 %
Ordinary shares
15
5 %
Ordinary shares
9
3 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 0
    Operating profit 2025: NOK -139,791
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222020
Total operating income
1,194,217
644,000
0
78,220
0
Annual Total Result
-2,309,383
57,085
-45,885
-5,182
0
Total assets
5,938,466
7,521,403
1,330,453
90,068
30,000
Total liabilities
5,906,269
6,419,970
1,293,681
94,544
0
Total equity
32,197
1,101,433
36,772
-4,476
30,000

P&L

Year20252024202320222020
Total operating income
1,194,217
644,000
0
78,220
0
Total operating costs
3,315,928
442,949
45,514
83,366
0
Operating result
-2,121,710
201,051
-45,514
-5,146
0
Financial income/costs
-187,672
-143,966
-371
-36
0
Profit before tax
-2,309,383
57,085
-45,885
-5,182
0
Total tax & extraordinary income/cost
0
0
0
0
0
Annual Total Result
-2,309,383
57,085
-45,885
-5,182
0

Balance overview

Year20252024202320222020
Total fixed assets
4,506,071
4,744,743
172,120
15,470
0
Total current assets
1,432,395
2,776,660
1,158,333
74,598
30,000
Total assets
5,938,466
7,521,403
1,330,453
90,068
30,000
Short term debt
5,906,269
6,419,970
243,681
94,544
0
Long term debt
0
0
1,050,000
0
0
Total liabilities
5,906,269
6,419,970
1,293,681
94,544
0
Contributed capital
2,301,856
1,061,709
54,133
30,000
30,000
Retained earnings
-2,269,658
39,725
-17,361
-34,476
0
Total equity
32,197
1,101,433
36,772
-4,476
30,000
Total equity and liabilities
5,938,466
7,521,403
1,330,453
90,068
30,000

Classification

21st company classification
BETA
Small company
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
71
Activity
Architectural and engineering activities; technical testing and analysis
71.2
Main industrial group
Technical testing and analysis
71.20
Industrial group
Technical testing and analysis
71.200
Industrial group
Technical testing and analysis